A Case of Immune-Mediated Necrotizing Myopathy in a 75-Year-Old with Anti-HMG-CoA Reductase Antibodies
Marshall Journal of Medicine · 31.01.2023 · 9 (1)
DOI: 10.33470/2379-9536.1387 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marshall Journal of Medicine, online erschienen am 31.01.2023. Verfasst von Dylan Smith und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Statins are the first-line therapy in the management of hyperlipidemia.Unfortunately, patients often stop the drug within the first year due to intolerable myalgias.Despite the removal of the drug, some patients experience myotoxicity, and their myalgia persists.In this case, a 75-year-old female presented with myalgias and an elevated creatine phosphokinase (CPK) level despite discontinuing statin therapy.Antibodies to 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA) were found in this patient; she was diagnosed with a rare form of statin-associated autoimmune myopathy, and she was successfully treated with leflunomide, methotrexate, and physical therapy.
Zitieren
APA
Smith, D., Flores, K., & Olajide, A. (2023). A Case of Immune-Mediated Necrotizing Myopathy in a 75-Year-Old with Anti-HMG-CoA Reductase Antibodies. Marshall Journal of Medicine, 9(1). https://doi.org/10.33470/2379-9536.1387
Vancouver
Smith D, Flores K, Olajide A. A Case of Immune-Mediated Necrotizing Myopathy in a 75-Year-Old with Anti-HMG-CoA Reductase Antibodies. Marshall Journal of Medicine. 2023;9(1). doi:10.33470/2379-9536.1387
BibTeX
@article{Smith2023,
author = {Smith, Dylan and Flores, Kassandra and Olajide, Adenrele},
title = {A Case of Immune-Mediated Necrotizing Myopathy in a 75-Year-Old with Anti-HMG-CoA Reductase Antibodies},
journal = {Marshall Journal of Medicine},
year = {2023},
volume = {9},
number = {1},
doi = {10.33470/2379-9536.1387}
}
EUVIMED